Please join us in welcoming the following new corporate partners contributing their support to the HBA mission.
CEO: Richard A. Gonzalez
AbbVie's mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, women's health, and gastroenterology, in addition to products and services across its Allergan Aesthetics portfolio.
CEO: Joshua H. Levine
Accuray develops, manufactures and sells radiation oncology systems that make cancer treatment shorter, safer, smarter and more effective.
Orphazyme US, Inc.
CEO: Kim Stratton
Orphazyme is a Danish biopharmaceutical company with a late-stage drug pipeline, developing new treatment options for orphan protein-misfolding diseases. We develop new therapies that mobilize a group of stress-response proteins, called heat-shock proteins. Heat-shock proteins help restore balance to cells affected by stress arising from misfolded proteins, protein aggregates, and lysosomal dysfunction. Our pipeline comprises three potential registration studies, with the first potential marketing authorization expected in 2021.
Ingersoll Rand Medical
CEO: Vicente Reynal
Our medical business unit provides flow control solutions to medical and laboratory equipment suppliers that are integrated into a final product. Those products deliver high levels of precision in demanding medical and laboratory environments, where technicians rely on our equipment for dependable and accurate performance for a variety of critical functions, including preparation of biologics and chemical samples for analysis. Our recent expansion into liquid pumps and liquid handling solutions opens additional new markets. The goal of our Medical business unit is to create a Premium Lab and Life company, which provides mission-critical flow control technologies and has engaged employees, who delight our customers with innovation and service.
CEO: Deepa Dahal
DKI Health is a consulting firm serving biopharma and healthcare organizations globally.